Sommerburg, O., Hämmerling, S. H., Schneider, P., Okun, J. G., Langhans, C., Leutz-Schmidt, P., . . . Stahl, M. (2021). CFTR modulator therapy with lumacaftor/ivacaftor alters plasma concentrations of lipid-soluble vitamins A and E in patients with cystic fibrosis. Antioxidants, 10(3), . https://doi.org/10.3390/antiox10030483
Chicago-Zitierstil (17. Ausg.)Sommerburg, Olaf, et al. "CFTR Modulator Therapy with Lumacaftor/ivacaftor Alters Plasma Concentrations of Lipid-soluble Vitamins A and E in Patients with Cystic Fibrosis." Antioxidants 10, no. 3 (2021). https://doi.org/10.3390/antiox10030483.
MLA-Zitierstil (9. Ausg.)Sommerburg, Olaf, et al. "CFTR Modulator Therapy with Lumacaftor/ivacaftor Alters Plasma Concentrations of Lipid-soluble Vitamins A and E in Patients with Cystic Fibrosis." Antioxidants, vol. 10, no. 3, 2021, https://doi.org/10.3390/antiox10030483.